Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Klencke Barbara Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 Klencke Barbara (Director) has filed a Form 4 on TScan Therapeutics, Inc.
Txns: Granted 36,524 options to buy @ $2.66, valued at $97.2k
01/24/2023 4 Klencke Barbara (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 28,125 options to buy @ $0.4688, valued at $13.2k
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2022 4 Klencke Barbara (Chief Medical Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 12,250 options to buy @ $12.15, valued at $148.8k
11/02/2021 4 Klencke Barbara (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $10.18, valued at $407.2k
11/02/2021 3 Klencke Barbara (Director) has filed a Form 3 on eFFECTOR Therapeutics, Inc.
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2020 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 5,950 shares @ $12.2201, valued at $72.7k
Bought 3,325 shares @ $12.2519, valued at $40.7k
02/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2019 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Bought 67,000 shares @ $0.4323, valued at $29k
Bought 54,000 shares @ $0.4499, valued at $24.3k
Bought 108,000 shares @ $0.4387, valued at $47.4k
03/05/2019 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 200,000 options to buy @ $1.96, valued at $392k
03/07/2018 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 180,360 options to buy @ $2.36, valued at $425.6k
03/08/2017 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on Sierra Oncology, Inc.
Txns: Granted 70,000 options to buy @ $1.45, valued at $101.5k
10/04/2016 4 Klencke Barbara (Chief Development Officer) has filed a Form 4 on ProNAi Therapeutics Inc
Txns: Granted 456,000 options to buy @ $1.82, valued at $829.9k
03/10/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy